Pharmaceutical care programmes for the elderly: economic issues.

Area of Science:

• Pharmacology
• Geriatrics
• Health Economics

Background:

• Pharmaceutical care optimizes drug therapy outcomes and patient quality of life.
• Elderly patients face higher risks of drug-related issues, including adverse reactions and noncompliance.
• Economic evaluations of pharmaceutical care show variable results and generalizability challenges.

Purpose of the Study:

• To review the economic benefits and quality of life impacts of pharmaceutical care for the elderly.
• To critically appraise existing studies on pharmaceutical care for the elderly.
• To identify the need for standardized data collection in economic analyses of pharmaceutical care programs.

Main Methods:

• Literature review of studies on pharmaceutical care for the elderly.
• Critical appraisal of research designs and economic evaluation methodologies.
• Analysis of challenges in measuring health-related quality of life in diverse elderly populations.

Main Results:

• Economic benefits of pharmaceutical care are inconsistently reported, with limited generalizability due to methodological limitations.
• Robust research designs are scarce, hindering reliable economic evaluations.
• International data pooling is difficult due to healthcare system disparities and varied data collection methods.

Conclusions:

• Standardized data collection approaches are essential for accurate economic analyses of pharmaceutical care programs for the elderly.
• Addressing challenges in measuring health-related quality of life is vital for comprehensive program evaluation.
• Further rigorous research is needed to establish the economic value and impact of pharmaceutical care in geriatric populations.